Cognito Therapeutics
Latest round
- Series C
Last raised
- Mar 2026
Total raised
- $178M
Investors
- 9
About Cognito Therapeutics
a. Cognito Therapeutics, operates as a developer of a headset to treat neurodegenerative diseases and improve human cognitive performance.a. Cognito Therapeutics operates as a developer of disease-modifying therapeutic interventions for neurodegenerative diseases and human cognitive performance. In March 2026, Cognito Therapeutics, Inc. Cognito Therapeutics provides an investigational therapeutic platform that delivers non-invasive neuromodulation by using sensory stimulation to evoke gamma oscillations in the brain with personalized treatments, adjustable fit, and self-administered features. The company's platform treats a range of neurodegenerative diseases, including Alzheimer’s disease, and is personalized based on the brain’s responses. Cognito Therapeutics generates revenue by commercializing physician-prescribed, non-invasive neurostimulation devices for Alzheimer’s and neurodegenerative diseases, earning income through device sales, clinical partnerships, and future reimbursement-based distribution following regulatory approvals and market launch.
Who invested in Cognito Therapeutics
9 investors across 2 rounds
See all investors in Cognito Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cognito Therapeutics
Who invested in Cognito Therapeutics?
Cognito Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cognito Therapeutics raised?
Cognito Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cognito Therapeutics last raise money?
Cognito Therapeutics's most recent round on record is a Series C, in Mar 2026.
What does Cognito Therapeutics do?
Cognito Therapeutics is a medical devices & equipment company.
Where is Cognito Therapeutics headquartered?
Cognito Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Cognito Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Cognito Therapeutics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Cognito Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.